Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

FDA Says There is Shortage of Mylan’s Epipen in US

FDA Says There is Shortage of Mylan’s Epipen in US

2018-05-15

Food and Drug Administration (FDA), on Wednesday, added EpiPen, a lower-dose version called EpiPen Jr, and Mylan's own generic versions ...

FDA Approves Tafinlar-Mekinist Combination for the Treatment of ATC

FDA Approves Tafinlar-Mekinist Combination for the Treatment of ATC

2018-05-15

Data from trials in BRAF V600E mutation-positive, metastatic melanoma or lung cancer and results in other BRAF V600E mutation-positive r...

Directa Plus And Arvind Limited Sign Exclusive Collaboration Agreement

Directa Plus And Arvind Limited Sign Exclusive Collaboration Agreement

2018-05-14

Directa Plus’ graphene-based products can be used in a variety of ways to alter or enhance the properties of conventional Denim fabrics, and to produce ‘smart’ clothing for different purposes and environments.

UAE's Neopharma and Japan's ASKA Pharma to Set up India JV

UAE's Neopharma and Japan's ASKA Pharma to Set up India JV

2018-05-09

The unit, to be operational by 2020, will manufacture oral solid dosage forms, oral liquids and topical preparations, and will have a pe...

Sun Pharma Enters Anti-fungal Powder OTC Category

Sun Pharma Enters Anti-fungal Powder OTC Category

2018-05-09

According to a company press release, Abzorb’s unique combination of talc & starch ensures superior sweat absorption, and clotrimazole, ...

Pharmexcil to Organise iPHEX Expo in New Delhi from May 8

Pharmexcil to Organise iPHEX Expo in New Delhi from May 8

2018-05-09

About $17-bn exports form a major part of the Indian pharmaceutical industry’s turnover of about $33-bn. The country has built a global brand as ‘Pharmacy of the world’ with about 930 recognised pharmacy colleges, 1400 WHO GMP approved manufacturing units

Biocon's Q4 Net Profit up Marginally; Annual Profit Dips 39%

Biocon's Q4 Net Profit up Marginally; Annual Profit Dips 39%

2018-05-09

For the full year ended March 31, the company saw its net profit decline 39 per cent to Rs. 372-crore, from Rs. 612-crore in FY17. Revenues grew just 6 per cent to Rs. 4,336-crore in FY18, against an 18 per cent growth to Rs. 4,079-crore in the previous.

Import Tariffs On Cancer Drugs Cut To Zero

Import Tariffs On Cancer Drugs Cut To Zero

2018-05-02

All types of cancer treatments, including chemotherapy drugs, alkaloid-based drugs, and imported traditional Chinese medicines used for ...

Mereo BioPharma's Rationale for Halting IPO Draws Skepticism

Mereo BioPharma's Rationale for Halting IPO Draws Skepticism

2018-04-28

Data is expected in June from the Phase IIb trial of BPS-804 for osteogenesis imperfecta, and if that data is positive, might add fuel t...

Werfen Sales Increases over 13 Percent

Werfen Sales Increases over 13 Percent

2018-04-28

As a result, the Critical Care business line has evolved into Acute Care Diagnostics, providing comprehensive solutions for emergency ca...

PaxVax Announces the Initiation of Phase 2b Trial for Its Chikungunya Vaccine

PaxVax Announces the Initiation of Phase 2b Trial for Its Chikungunya Vaccine

2018-04-28

Chikungunya virus is an arthropod-borne virus (arbovirus), closely related to other viruses in Africa, South America and Australia that ...

FDA Warns of Serious Immune System Reaction with Lamotrigine

FDA Warns of Serious Immune System Reaction with Lamotrigine

2018-04-28

A diagnosis of HLH can be established if a patient has at least five of the following eight signs or symptoms: Fever and rash

Röchling Expanding Its Medical Division

Röchling Expanding Its Medical Division

2018-04-27

Röchling Group has invested 35 million euros ($42.6 million) to expand and scale up medical production capacity at its site in Neuhaus am Rennweg, Germany.

Dr. Reddy's Gets EIR from USFDA for Cuernavaca Plant in Mexico

Dr. Reddy's Gets EIR from USFDA for Cuernavaca Plant in Mexico

2018-04-25

Hyderabad-based Dr. Reddy’s Laboratories said it has received establishment inspection report (EIR) from the US health regulator for its Cuernavaca facility in Mexico. The company had earlier said in a regulatory filing that audit of its active...

Alembic Pharma Gets USFDA Nod for Acyclovir Ointment

Alembic Pharma Gets USFDA Nod for Acyclovir Ointment

2018-04-25

Alembic Pharma said it has received approval from the USFDA for its abbreviated new drug application (ANDA) for Acyclovir ointment USP, 5 per cent. The ointment is used for the treatment of genital herpes. The approved ointment is therapeutically...

India: Rakesh Kumar Vats Given Additional Charge of NPPA Chairman

India: Rakesh Kumar Vats Given Additional Charge of NPPA Chairman

2018-04-25

Mr. Rakesh Kumar Vats, Additional Secretary, Ministry of Health and Family Welfare has been given the additional charge of Chairman of drug price regulator NPPA, an official statement said.

Natco Gets Favourable Ruling in US

Natco Gets Favourable Ruling in US

2018-04-25

Hyderabad-based Natco Pharma Ltd. has been awarded a favourable judgment in the US Court of Appeals for the Federal Circuit ruling on patent-related to Teva’s Copaxone (treat multiple sclerosis). The court of appeals had reversed a district court’s...

Milan Paleja to Head Novartis India's Pharmaceuticals Business

Milan Paleja to Head Novartis India's Pharmaceuticals Business

2018-04-25

Novartis India has appointed Mr. Milan Paleja as its new President. He will succeed Mr. Jawed Zia, who left the drug maker in March for rival Abbott India. Mr. Paleja, previously President and head of pharmaceuticals for Novartis Indonesia, will also...

Bharat Biotech Unveils New Brand Identity

Bharat Biotech Unveils New Brand Identity

2018-04-25

Vaccine maker Bharat Biotech has unveiled its new corporate logo and vision for the future. With its new logo and tag line ‘Lead Innovation’, the Hyderabad-based company is underlining its focus for developing new made-in-India molecules to prevent...

AstraZeneca to Invest $90-Mn in India over Next 5 Years

AstraZeneca to Invest $90-Mn in India over Next 5 Years

2018-04-25

Biopharmaceutical firm AstraZeneca has revealed plans to invest $90-mn (around Rs. 590-crore) in India over the next five years. The announcement followed the signing of a bilateral innovation partnership for a sustainable future between Sweden and India.

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message